or Try an Advanced Search...

    Technical Analysis for PASG - Passage Bio, Inc.

    Grade Last Price % Change Price Change
    C 1.55 3.14% 0.05
    PASG closed down 5.06 percent on Wednesday, May 8, 2024, on 54 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical PASG trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 3.14%
    Outside Day Range Expansion 3.14%
    Wide Bands Range Expansion 3.14%
    Overbought Stochastic Strength 3.14%
    Upper Bollinger Band Touch Strength 3.14%
    Above Upper BB Strength -2.08%
    Gapped Up Strength -2.08%
    Overbought Stochastic Strength -2.08%
    Upper Bollinger Band Touch Strength -2.08%
    20 DMA Support Bullish 9.72%
    Older End-of-Day Signals for PASG ...

       Recent Intraday Alerts

    Alert Time
    Up 5% 20 minutes ago
    Rose Above Upper Bollinger Band about 4 hours ago
    Up 3% about 4 hours ago
    Down 1% about 4 hours ago
    Up 2% about 4 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PASG Chart by TradingView
    Basic chart:

    Profile

    Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Organ Systems Rare Diseases Central Nervous System Disorders Nervous System Disorders Lipid Storage Disorders Monogenic Medicine Products Gm1 Rare Tadataka Yamada

    Is PASG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 22 Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
    Mar 5 Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program
    Mar 4 Passage Bio files for $200M mixed shelf offering
    Mar 4 Passage Bio GAAP EPS of -$1.86 beats by $0.04
    Mar 4 Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
    Feb 27 Passage Bio to Participate in Upcoming Investor Conferences
    Feb 12 We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully
    Jan 31 Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    Dec 20 Passage Bio stock climbs 9% on dementia study, program update
    Dec 20 Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
    See more PASG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.79
    52 Week Low 0.5751
    Average Volume 346,616
    200-Day Moving Average 0.95
    50-Day Moving Average 1.38
    20-Day Moving Average 1.30
    10-Day Moving Average 1.36
    Average True Range 0.13
    RSI (14) 60.32
    ADX 16.88
    +DI 22.57
    -DI 13.09
    Chandelier Exit (Long, 3 ATRs) 1.24
    Chandelier Exit (Short, 3 ATRs) 1.50
    Upper Bollinger Bands 1.51
    Lower Bollinger Band 1.09
    Percent B (%b) 0.97
    BandWidth 32.45
    MACD Line 0.04
    MACD Signal Line 0.00
    MACD Histogram 0.0339
    Fundamentals Value
    Market Cap 82.23 Million
    Num Shares 54.8 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -0.73
    Price-to-Sales 0.00
    Price-to-Book 0.43
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.79
    Resistance 3 (R3) 1.80 1.72 1.74
    Resistance 2 (R2) 1.72 1.65 1.71 1.72
    Resistance 1 (R1) 1.61 1.60 1.57 1.60 1.71
    Pivot Point 1.53 1.53 1.51 1.52 1.53
    Support 1 (S1) 1.42 1.46 1.38 1.41 1.29
    Support 2 (S2) 1.34 1.41 1.33 1.28
    Support 3 (S3) 1.23 1.34 1.26
    Support 4 (S4) 1.22